The impact of right ventricular energy failure on the results of pulmonary endarterectomy and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension

Yıl 2024, , 129 - 136, 31.05.2024

Redwan Seid Busery , Bülent Mutlu , Dursun Akaslan , Emre Aslanger , Bedrettin Yildizeli Halil Atas

https://doi.org/10.5472/marumj.1484403

Öz

Objective: We aimed to investigate the effect of right ventricular energy failure (RVEF) on hemodynamic and clinical outcomes in
patients diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH) undergoing pulmonary endarterectomy (PEA)
surgery or balloon pulmonary angioplasty (BPA).
Patients and Methods: A total of 100 CTEPH patients planned for PEA or BPA were included in the study. Based on the presence of
RVEF during diagnosis, patients divided into two groups. Hemodynamic data from right heart catheterization (RHC) were compared
before and after procedures in 3-6 months follow up period.
Results: Patients with RVEF revealed a decrease in mean pulmonary artery pressure (mPAP) from 54.67±12.27 mmHg to 36.12±11.76
mmHg (p:<0.001), mean right atrial pressure (mRAP) from 13.40±4.08 mmHg to 9.76±4.56 mmHg (p:0.003), and pulmonary vascular
resistance (PVR) from 11.36±5.15 Wood Units (WU) to 5.46±3.30 WU (p <0.001). In the non-RVEF group, mPAP decreased from
38.82±12.61 mmHg to 30.81±10.57 mmHg (p:<0.001), mRAP from 7.09±3.02mmHg to 7.15±3.07mmHg (p: 0.917), and PVR from
6.33±3.65 WU to 4.09±2.31 WU (p:<0.001).
Conclusion:The presence of RVEF at the time of diagnosis in CTEPH patients does not have a negative impact on early perioperative
and 3-month postoperative outcomes following PEA or BPA. This high-risk patient group demonstrated significant hemodynamic
and clinical benefits from both PEA and BPA.

Anahtar Kelimeler

Chronic thromboembolic pulmonary hypertension, Right ventricular energ failure, Pulmonary endarterectomy, Pulmonary balloon angioplasty

Kaynakça

• Brida, Jørn Carlsen, Andrew J S Coats, et al ESC/ERS Scientific Document Group , 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension; Eur Heart J 2022;43:3618-731. doi:10.1093/eurheartj/ehac237
• Madani MM, Auger WR, Pretorius V, et al. Pulmonary endarterectomy: recent changes in a single institution’s experience of more than 2,700 patients. Ann Thorac Surg 2012;94:97-103.
• Tsugu T, Murata M, Kawakami T, et al. Changes in right ventricular dysfunction after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. Am J Cardiol 2016;118. doi:10.1016/j. amjcard.2016.07.016
• Inami T, Kataoka M, Yanagisawa R, et al. Long-term outcomes after percutaneous transluminal pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Circulation 2016;134:2030-2. doi:10.1161/ Circulationaha.116.024201
• Viray MC, Bonno EL, Gabrielle ND, et al. Role of pulmonary artery wedge pressure saturation during right heart catheterization: a prospective study. Circ Heart Fail 2020;13:e007981.
• Rosenkranz S, Howard SL, Gomberg-Maitland M, Hoeper MM. Systemic consequences of pulmonary hypertension and right-sided heart failure. Circulation 2020;141:678-93. doi: 10/1161/CIRCULATIONAHA.116.022362
• Aslanger E, Akaslan D, Atas H, Kocakaya D, Yıldızeli B, Mutlu B, Right ventricular energy failure predicts mortality in patients with pulmonary hypertension. Am J Cardiol 2023;193:19-27. doi:10.1016/j.amjcard.2023.01.046
• Delcroix M, Torbicki A, Gopalan D, et al. ERS statement on chronic thromboembolic pulmonary hypertension. Eur Respir J 2020;57:2002828.
• Fares WH, Bellumkonda L, Tonelli AR, et al Right atrial pressure/pulmonary artery wedge pressure ratio: a more specific predictor of survival in pulmonary arterial hypertension. J Heart Lung Transplant 2016;35:760-7.
• Claessen G, La Gerche A, Dymarkowski S, Claus P, Delcroix M, Heidbuchel H. Pulmonary vascular and right ventricular reserve in patients with normalized resting hemodynamics after pulmonary endarterectomy. J Am Heart Assoc 2015;4:e001602. doi: 10.1161/JAHA.114.001602.
• McCabe C, White PA, Hoole SP, et al Right ventricular dysfunction in chronic thromboembolic obstruction of the pulmonary artery: a pressure-volume study using the conductance catheter. J Appl Physiol 2014; 116: 355-63.
• Hsu S, Houston BA, Tampakakis E, et al Right ventricular functional reserve in pulmonary arterial hypertension. Circulation 2016; 133: 2413-22.
• S. Miyamoto, N. Nagaya, T. Satoh, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2020;161:487-92.
• Guth S, Wiedenroth CB, Rieth A, et al. Exercise right heart catheterisation before and after pulmonary endarterectomy in patients with chronic thromboembolic disease. Eur Respirat J 2018; 52: 1800458; doi: 10.1183/13993.003.00458-2018
• Cannon JE, Su L, Kiely DG, et al. Dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy: results from the United Kingdom National Cohort. Circulation 2016;133:1761-71. doi: 10.1161/Circulationaha.115.019470.
• Vriz O, Veldman G, Gargani L, et al. Age-changes in right ventricular function-pulmonary circulation coupling: from pediatric to adult stage in 1899 healthy subjects. The RIGHT heart international NETwork (RIGHT-NET).Int J Cardiovasc Imaging. 2021; 37: 3399-411.
• Gorter TM, van Veldhuisen DJ, Voors AA, et al. . Right ventricular-vascular coupling in heart failure with preserved ejection fractio and pre – vs. post-capillary pulmonary hypertension. Eur Heart J Cardiovasc Imaging 2018; 19: 425-32.
• Ruigrok D, Handoko ML, Meijboom LJ, et al. Noninvasive follow-up strategy after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. ERJ Open Res 2022;8:00564-2021. doi: 10.1183/23120.541.00564-2021.
• Brenot P, Jaïs X, Taniguchi Y, et al. French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Eur Respir J 2019;53:1802095. doi: 10.1183/13993.003.02095-2018
• Mizoguchi H, Ogawa A, Munemasa M, Mikouchi H, Ito H, Matsubara H. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 2012 ;5:748-55. doi: 10.1161/Circinterventions.112.971077.